Gunther Birznieks, SVP, Business Development at Vanda Pharmaceuticals Inc. (VNDA), sold 27,118 shares at $11.27 ($305K) on 2022-03-02, disclosed to the SEC on 2022-03-02.
Seasonal sale ($305k) by SVP, Business Development — this insider has traded VNDA in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.19 | 4,084 | $46K | 15.0% |
| 2 | $11.27 | 11,517 | $130K | 42.5% |
| 3 | $11.27 | 11,517 | $130K | 42.5% |
| Total | $11.26 avg | 27,118 | $305K | 100% |
| Filing → |
| VNDA | SELL | 2023-03-06 | $209K | — | Filing → |
| VNDA | SELL | 2021-03-03 | $748K | — | Filing → |
| VNDA | SELL | 2020-03-04 | $363K | — | Filing → |